Skip to Main Content

Browse issues

Volume 104, Issue 8, August 2019

Print and Online

Case Reports

Camila Kruschewsky Falcao and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3245–3248, https://doi.org/10.1210/jc.2018-02221

A case report about the development of lipodystrophy 2 months after the initiation of nivolumab, suggesting a cause/effect relationship.

Catherine Cardot-Bauters and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3362–3366, https://doi.org/10.1210/jc.2019-00175

We reported a case of succinate dehydrogenase complex B mosaicism and showed that it is responsible for a functional paraganglioma with recurrence and early onset.

Pinaki Dutta and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3539–3544, https://doi.org/10.1210/jc.2019-00432

AIP mutation-driven gigantism with pituitary apoplexy and aggressive tumor growth was controlled by multimodal treatment: surgery, octreotide-LAR, radiotherapy, temozolomide, bevacizumab, and pegvisomant.

Mini-Review

Gregory A Kaltsas and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3108–3123, https://doi.org/10.1210/jc.2018-01871

We have reviewed nonneuroendocrine neoplasms of the pituitary region and identified novel predictive markers and evolving therapies that could help optimize treatment in a multidisciplinary setting.

Clinical Research Articles

Angad Jolly and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3049–3067, https://doi.org/10.1210/jc.2019-00248

Exome sequencing was used to investigate genes and mutational mechanisms contributing to primary ovarian insufficiency, and to gain insights into disease biology and underlying pathophysiology.

Hilal Sekizkardes and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3068–3076, https://doi.org/10.1210/jc.2018-02787

Metreleptin treatment of 12 months led to similar improvements in HbA1c, insulin dose, and triglycerides in patients with familial partial lipodystrophy due to PPARG vs LMNA pathogenic variants.

Peter S Hamblin and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3077–3087, https://doi.org/10.1210/jc.2019-00139

During the course of hospital admission, diabetic ketoacidosis developed more frequently in SGLT2 inhibitor users vs nonusers, with an OR of 37.4 (95% CI, 8.0 to 175.9; P < 0.0001).

Andrea Palermo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3088–3096, https://doi.org/10.1210/jc.2018-02216

In vitro findings suggest the existence of interplay between PTH and irisin metabolism that seems to be confirmed by a significant reduction in irisin concentration in postmenopausal women with PHPT.

Maria Pia Adorni and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3097–3107, https://doi.org/10.1210/jc.2018-02027

Hypogonadal individuals display reduced high-density lipoprotein cholesterol efflux capacity and increased cholesterol serum capacity. These features reflect a proatherogenic potential, independent of lipoprotein levels.

Emily A Southmayd and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3131–3145, https://doi.org/10.1210/jc.2019-00089

Bone turnover was assessed as a function of energy and estrogen status in exercising women. The combination of energy and estrogen deficiency negatively affected bone formation and bone turnover rate.

Chi Chen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3148–3156, https://doi.org/10.1210/jc.2018-01874

A genetic decrease in 25(OH)D was associated with lower T levels, providing evidence in support of a causal role of vitamin D in raising T levels, using Mendelian randomization analysis.

Marie J E Walenkamp and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3157–3171, https://doi.org/10.1210/jc.2018-02065

A clinical score (based on birth size, height, head circumference, and IGF-1) can select patients for IGF1R analysis. The response to GH therapy is moderate in carriers of heterozygous IGF1R defects.

Naomi Pode-Shakked and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3172–3180, https://doi.org/10.1210/jc.2018-02468

A strategy using cutoff levels adjusted for both GA and BW significantly reduced FP rates of NBS for CAH in 10 years' experience of the Israeli NBS program.

Anna Aulinas and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3181–3191, https://doi.org/10.1210/jc.2018-02608

Plasma OT levels are low and psychopathy is increased in hypopituitary men with CDI, suggestive of a possible OT-deficient state.

Judith Gerards and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3192–3202, https://doi.org/10.1210/jc.2019-00299

Analysis of 161 patients with primary hyperaldosteronism (PA) and comparison with matched controls revealed that autonomous cortisol secretion in PA is associated with impaired glucose homeostasis.

Arjola Bano and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3203–3212, https://doi.org/10.1210/jc.2019-00072

This study investigated whether coagulation factors mediate the role of thyroid function on cardiovascular disease. VWF:Ag and fibrinogen partly explained the link of FT4 with cardiovascular disease.

Jun Inaishi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3213–3222, https://doi.org/10.1210/jc.2018-01782

The genetic risk score generated for type 2 diabetes improved the predictive ability of incident type 2 diabetes from a model with environmental risk factors in a general Japanese population.

Henriette Ejlsmark-Svensson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3223–3232, https://doi.org/10.1210/jc.2018-02456

Effect of parathyroidectomy on arterial stiffness and BP in patients with primary hyperparathyroidism. No beneficial effect on arterial stiffness and BP was observed after PTX.

Christoffer Martinussen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3233–3244, https://doi.org/10.1210/jc.2018-02661

GLP-1 responses to dietary carbohydrates were exaggerated after gastric bypass. Prolonged digestion led to greatly enhanced GLP-1 secretion in unoperated subjects, but less so after gastric bypass.

Kevin R Short and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3249–3261, https://doi.org/10.1210/jc.2018-02698

Several plasma amino acids and their metabolites were altered in American Indian adolescents with obesity and correlated with insulin sensitivity but did not change in response to exercise training.

Melanie Cree-Green and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3265–3278, https://doi.org/10.1210/jc.2019-00129

Adolescents with obesity with type 1 diabetes were randomized to 3 months of metformin or placebo. Youth who received metformin had an improvement in peripheral, but not hepatic, insulin sensitivity.

Yu-Jih Su and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3279–3286, https://doi.org/10.1210/jc.2018-02526

We conducted a cohort study and found metformin use in diabetic psoriasis patients do not increase the risk of mortality, severe psoriasis, psoriasis-related admission, and any-cause re-admission.

Liora Lazar and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3287–3295, https://doi.org/10.1210/jc.2019-00233

Combined GH/GnRHa therapy is beneficial in increasing AHt outcome in children with ISS with early/normal puberty and in adolescents naïve to GH treatment who are in midpuberty at start of therapy.

Olga Vaccaro and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3296–3302, https://doi.org/10.1210/jc.2019-00361

A parsimonious set of clinical variables identifies patients with diabetes in whom add-on pioglitazone to metformin confers cardiovascular protection, thus supporting more personalized diabetes care.

Nicola Napoli and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3303–3310, https://doi.org/10.1210/jc.2018-02539

We found lower risk of fracture with higher insulin resistance in older adults without diabetes. This inverse association was lost after adjustment for BMI and BMD.

Linda E Watson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3311–3319, https://doi.org/10.1210/jc.2018-02736

Gastric emptying is slowed with aging but otherwise more rapid in relatively well-controlled T2DM patients, in whom the postprandial blood glucose excursion is related to gastric emptying.

Yan Zhao and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3320–3326, https://doi.org/10.1210/jc.2018-02713

Prenatal exposure to particulate air pollutants of PM2.5 and PM10 may decrease circulating levels of 25(OH)D in pregnant women and increase the odds of maternal vitamin D deficiency.

Diana Barb and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3327–3336, https://doi.org/10.1210/jc.2018-02414

We assessed the relationship between plasma FGF21 levels and steatohepatitis in patients with NAFLD. We found that higher FGF21 levels correlated with the severity of liver fibrosis.

Andrea K Steck and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3337–3344, https://doi.org/10.1210/jc.2018-02196

In Ab+ children, CGM accurately predicted progression to clinical diabetes. .

Fu-Rong Li and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3345–3354, https://doi.org/10.1210/jc.2018-02536

We observed a U-shaped association between HbA1c and all-cause mortality among participants with diabetes and an asymmetric reverse J-shaped association among those without diabetes.

Laura C Torchen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3355–3361, https://doi.org/10.1210/jc.2018-02313

We found similar degrees of hyperandrogenemia in premenarchal daughters of women with PCOS and girls with obesity but differing anti-Müllerian hormone levels, suggesting ovarian folliculogenesis differs in these groups.

Zhi-Hao Li and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3370–3378, https://doi.org/10.1210/jc.2018-02511

In this community-based prospective cohort, U-shaped associations were found for high-density lipoprotein cholesterol with all-cause and cardiovascular mortality among the elderly.

Fredrika Schill and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3379–3388, https://doi.org/10.1210/jc.2019-00012

HER2-positive breast carcinomas are especially prone to disseminate to the pituitary. Metastases often appear late, may be single, and grow slowly. Hypocortisolism is the most common hormone deficit.

Mercedes del Río-Moreno and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3389–3402, https://doi.org/10.1210/jc.2019-00021

Dysregulations of the splicing machinery precede the development of steatosis and define different molecular phenotypes of nonalcoholic fatty liver disease (NAFLD). This study provides information to explore strategies for NAFLD.

Andrew A Dwyer and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3403–3414, https://doi.org/10.1210/jc.2018-02697

FHH in men is a reversible form of GnRH deficiency characterized by neuroendocrine deficits similar to those of women with HA.

Xiang Zhou and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3419–3427, https://doi.org/10.1210/jc.2018-02297

The broad etiological spectrum and change pattern of PST are described in a large series from a single center, and diagnostic and management approaches are discussed.

Amanda J Berberich and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3428–3436, https://doi.org/10.1210/jc.2018-02574

A whole exon deletion in GCK was found in two unrelated families exhibiting a MODY phenotype using a bioinformatics approach to identify copy number variations.

Sara G Creemers and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3437–3449, https://doi.org/10.1210/jc.2019-00217

The in vitro effects of osilodrostat on human adrenal steroidogenesis are studied compared with metyrapone and ketoconazole. We show that it is a promising novel treatment of Cushing syndrome.

Serge Ferrari and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3450–3461, https://doi.org/10.1210/jc.2019-00271
Bertrand Barres and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3462–3472, https://doi.org/10.1210/jc.2018-02680

presTg (<10 µg/L) and TRI (<60%) predict excellent response in patients with DTC managed by thyroidectomy and RAI remnant ablation.

Estelle Everett and Nestoras Mathioudakis
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3473–3480, https://doi.org/10.1210/jc.2018-02232

We compared the association of area deprivation and other predictors with recurrent DKA admissions in pediatrics and adults and found that deprivation had a more pronounced effect in pediatrics.

Alfonso Galderisi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3481–3490, https://doi.org/10.1210/jc.2019-00161

Fructose, but not glucose, ingestion causes a rapid and sustained rise in circulating GLP-1 levels in adolescents with obesity. The fructose-induced GLP-1 increase is associated with reduced β-cell function.

Karn Wejaphikul and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3491–3500, https://doi.org/10.1210/jc.2018-02794

Met256-TRα1/Met310-TRβ1 determine the differential bioactivity of T3 vs T4, providing the molecular basis for the clinical concept that T4 functions as prohormone and T3 as bioactive hormone.

Mari C Vázquez-Borrego and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3501–3513, https://doi.org/10.1210/jc.2019-00056

Biguanides reduced aggressiveness features (e.g., proliferation, apoptosis) in pituitary neuroendocrine tumors, opening avenues to explore their potential as drugs to treat these pathologies.

Ha T Mai and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3514–3520, https://doi.org/10.1210/jc.2018-02614

In this population-based study, we found that whereas 35% of fractures were attributable to low BMD and advancing age, most postfracture mortality was attributable to advancing age.

Stacey L Simon and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3525–3534, https://doi.org/10.1210/jc.2018-02385

Girls with PCOS had later circadian timing of melatonin than did obese control subjects. Melatonin secretion after wake was associated with insulin resistance and higher serum levels of testosterone.

Václav Hána and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3545–3556, https://doi.org/10.1210/jc.2018-01926

With a GC-MS/MS technique, we measured 83 steroids in sera from 52 patients with adrenal incidentalomas and 26 controls, revealing a steroid fingerprint in patients with subclinical hypercortisolism.

Riccardo Giannini and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3557–3575, https://doi.org/10.1210/jc.2018-01167

The immune gene expression profiling of thyroid cancers revealed the existence of at least two immune phenotypes that could influence the choice of immunotherapeutic strategies for treatment.

Sarah M Bristow and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3576–3584, https://doi.org/10.1210/jc.2019-00111

This analysis of observational data from a clinical trial shows that dietary calcium intake is not associated with change in bone density over 6 years in postmenopausal women with osteopenia.

Suet Ching Chen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3585–3594, https://doi.org/10.1210/jc.2019-00084

Micro-MRI-based assessment of bone microarchitecture demonstrated poorer trabecular bone in children with type 1 diabetes compared with healthy controls.

Commentaries

Tim I M Korevaar and Robin P Peeters
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3262–3263, https://doi.org/10.1210/jc.2019-00336

This paper discusses the manuscript by Sitoris et al., published in a recent issue of JCEM, which evaluated the American Thyroid Association’s targeted screening approach for thyroid disease in pregnancy.

David R Weber
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3521–3523, https://doi.org/10.1210/jc.2019-00658

This commentary on Napoli et al. reviews the contributions of insulin resistance to bone density and skeletal fragility.

Letters to the Editor

Panagiotis Anagnostis and Dimitrios G Goulis
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Page 3124, https://doi.org/10.1210/jc.2019-00413
Frida Emanuelsson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3125–3126, https://doi.org/10.1210/jc.2019-00532
Sean J Iwamoto and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3127–3128, https://doi.org/10.1210/jc.2019-00249
Jerilynn C Prior
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3129–3130, https://doi.org/10.1210/jc.2019-00524
Cheryl Rockman-Greenberg
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3146–3147, https://doi.org/10.1210/jc.2018-02413
Ali Al-Khazaali and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Page 3367, https://doi.org/10.1210/jc.2019-00373
Berit A M Larsson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3368–3369, https://doi.org/10.1210/jc.2019-00486
Jan M Wit and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3415–3416, https://doi.org/10.1210/jc.2019-00468
Martin Chalumeau and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3417–3418, https://doi.org/10.1210/jc.2019-00564
Elena Gonzalez Rodriguez and Olivier Lamy
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3535–3536, https://doi.org/10.1210/jc.2019-00747
Richard Eastell and Clifford J Rosen
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages 3537–3538, https://doi.org/10.1210/jc.2019-00777

Corrections

The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Page 3264, https://doi.org/10.1210/jc.2019-01113
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Page 3524, https://doi.org/10.1210/jc.2019-01393

Print Abstracts—Full Content Online Only

Clinical Research Article

P J Manning and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages W4–W14, https://doi.org/10.1210/jc.2018-00197

Letter to the Editor

Jean-Christophe Lagacé and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 8, August 2019, Pages W1–W3, https://doi.org/10.1210/jc.2018-02306
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close